dual agonist glp 1 Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Beyond metabolic benefits: The underexplored

It is one of the most exciting frontiers in regenerative medicine today

NianYIskeJMaenosonoRMinamiKHeinbokelTQuanteMet alTargeting Age-Specific Changes in CD4+ T Cell Metabolism Ameliorates Alloimmune Responses and Prolongs Graft Survival

5 : 473476 Chandrasekaran K, Hatanpaa K, Brady DR, Rapoport SI

Pine bark phenolic extracts, current uses, and potential food applications: A review

It has a host of other benefits such as acting as an antioxidant and helping to protect cells from damage

Lower levels of IGF-1 and growth hormone in older adults have been linked with (5, 14): increased fat mass increased cardiovascular risk decreased muscle mass and strength lower cognitive function lower bone density limited joint mobility Several of these traits are seen in frail older adults